SHREYA BHANDARI; HASMITHA KAMINENI. Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 receptors in Breast Cancer Patients. International Journal for Research in Applied Sciences and Biotechnology, [S. l.], v. 8, n. 4, p. 104–109, 2021. Disponível em: https://ijrasb.com/index.php/ijrasb/article/view/204. Acesso em: 16 jul. 2024.